Management Inc. Opaleye serves as Executive at Imprimis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Management Inc. Opaleye has executed 364 insider transactions totaling $66.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 22, 2020 involved purchasing 5,000 shares valued at $25.1K.
Management Inc. Opaleye currently holds 449,844 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Management Inc. Opaleye has been a net buyer of IMMY stock. They have purchased $43.7M and sold $22.8M worth of shares.
Management Inc. Opaleye's most recent insider trade was on May 22, 2020, when they purchased 5,000 shares at $5.02 per share.
Get notified when new Form 4 filings are submitted
| $5.05 |
| Discretionary |
| May 21, 2020 | HROW | $940 | Purchase | 200 | $4.70 | Discretionary |
| May 21, 2020 | HROW | $48.4K | Purchase | 10,396 | $4.66 | Discretionary |
| May 20, 2020 | HROW | $1.3K | Purchase | 300 | $4.47 | Discretionary |
| May 20, 2020 | HROW | $5.4K | Purchase | 1,200 | $4.50 | Discretionary |
| Jan 2, 2020 | OCUL | $58.5K | Purchase | 15,000 | $3.90 | Discretionary |
| Dec 30, 2019 | OCUL | $59.5K | Purchase | 15,000 | $3.97 | Discretionary |
| Dec 30, 2019 | OCUL | $19.9K | Purchase | 5,000 | $3.97 | Discretionary |
| Mar 11, 2016 | IMMY | $164.3K | Purchase | 45,000 | $3.65 | Discretionary |
| Mar 11, 2016 | IMMY | $164.3K | Purchase | 45,000 | $3.65 | Discretionary |
| Mar 11, 2016 | IMMY | $162.0K | Purchase | 45,000 | $3.60 | Discretionary |
| Jun 30, 2015 | IMMY | $276.5K | Purchase | 35,000 | $7.90 | Discretionary |
| May 19, 2015 | IMMY | $22.4K | Purchase | 2,801 | $8.00 | Discretionary |